期刊文献+

酮内酯的抗耐药菌机制及结构修饰的研究进展 被引量:1

下载PDF
导出
摘要 细菌对大环内酯耐药的机制主要为靶点的修饰、核蛋白的变异和主动外排作用。酮内酯有两个作用靶点:23SrRNAⅤ区的A2058和Ⅱ区的A752,酮内酯通过与第二靶点A752结合,发挥其抗耐药菌活性。在此基础上对酮内酯进行结构修饰,合成出一系列具有抗耐药菌活性的化合物,本文简要综述了近年来酮内酯在这方面的研究进展。
机构地区 山东大学药学院
出处 《国外医学(药学分册)》 2005年第3期168-172,共5页 Foreign Medical Sciences(Section of Pharmarcy)
基金 国家自然科学基金资助项目(20372043)
  • 相关文献

参考文献17

  • 1Novotny GW, Jakobsen L, Andersen NM, et al . Ketolide antimicrobial activity persists after disruption of interactions with domain Ⅱ of 23S rRNA[ J ]. Antimicrob Agents Chemother, 2004, 48(10) : 3677 - 3683.
  • 2Weiss K, Guilbault C, Crotes L, et al. Genotypic characterization of macrolide-resistant strains of Streptococcus isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin [ J ]. J Antimicrob Chemother, 2002, 50(3) : 403 - 406.
  • 3Jalava J, Vaara M, Huovinen P. Mutation at the position 2058 of the 23S rRNA as a cause of macrolide resistance in Streptococcus pyogenes[ J ]. Ann Clin Microbiol Antimlcrob, 2004, 3(1) : 5.
  • 4Nilius AM, Ma Z. Ketolides: the future of the macrolides[ J ]? Curr Opin Pharmacol, 2002, 2(5) : 493 - 500.
  • 5Pihlajamaki M, Kataja J, Seppala H, et al . Ribosomal mutation in Streptococcus pneumoniae clinical isolates [ J ]. Antimicrob Agents Chemother, 2002, 46(3) : 654 - 658.
  • 6Tait-Kamradt A, Davies T, Appelbaum PC, et al. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus paneumoniae from Eastern Europe and Noah America [ J ]. Antimicrob Agents Chemother, 2000, 44(12) : 3395 - 3401.
  • 7Keyes RF, Carter JJ, Englund EE, et al. Synthesis and antibacterial activity of 6-O-arylbutynyl ketolides with improved activity against some key erythromycin-resistant pathogens[ J ]. J Med Chem, 2003,46(10) : 1795 - 1798.
  • 8Rolain JM, Maurin M, Bryskier A, et al. In vitro activities of telithromycin ( HMR3647 ) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii,Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis[ J ]. Antimicrob Agents Chemother, 2000, 44(5) : 1391 - 1393.
  • 9Beebe X, Yang F, Bui MH, et al. Synthesis and antibacterial of 6-O-arylpropargyl-9-oxime-11, 12-carbamate ketolides [ J ]. Bioorg Med Chem Lett, 2004, 14(10) : 2417 - 2421.
  • 10Ma Z, Oak RF, Brazzale A, et al. Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens[ J ]. J Med Chem, 2001, 44(24) : 4137 - 4156.

同被引文献23

引证文献1

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部